Viewing Study NCT01030302


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2025-12-26 @ 2:33 AM
Study NCT ID: NCT01030302
Status: COMPLETED
Last Update Posted: 2013-03-08
First Post: 2009-10-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Retreatment Study With Bortezomib for Multiple Myeloma
Sponsor: Janssen Korea, Ltd., Korea
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module